Tofacitinib/ Barcitinib/ Ruxolitinib Intermediates

1231930-33-8 and  1180132-17-5

(R)-3-Amino-piperidine dihydrochloride /// (R)-3-(Boc-Amino)piperidine  

Ethyl 3-(3-amino-4-(methyl amino)-N-(pyridin-2-yl) benzamido) propanoate /// 2-(4-Cyanophenylamino) Acetic Acid

 Manufacturing Intermediates of  Cas No. 1206124-13-1 and 957208-65-0

2-(4-nitrophenyl)ethanamine hydrochloride // 2-(2-Aminothiazol-4-yl)acetic acid// R)-2-(4-nitrophenethylamino)-1- Phenylethanol // (R)-2-(4-aminophenethylamino)-1-Phenylethanol HCL

A.R. Life sciences ( ARL) is a manufacturer of Bulk Drugs / API’s and Intermediates.  The company was established in the year 2007, head office located in Hyderabad, India. Company has an experienced and strong team of 200 + employees with strong client relationships with both International and domestic.  ARL has three manufacturing facilities, two located in Hyderabad (One facility USFDA approved) and a brand new facility commencing shortly in Vizag.  Infrastructure spread over  10 acres with reactor volume of ~136,000 liters (extendable upto 500,000 liters when fully occupied). Facilities are certified with ISO 9001-2015 and WHO GMP and the company follows cGLP and cGMP practices. In a very short span of time the company has grown into a vertically integrated company specializing in Intermediates and API’s covering various therapeutic areas.